Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Genetic Engineering (NGE) is a biotechnology company primarily focused on providing advanced genetic testing and molecular diagnostic services. The company specializes in identifying genetic predispositions for various hereditary conditions, as well as offering diagnostic solutions for infectious diseases and oncology. NGE operates modern laboratory facilities equipped for high-throughput sequencing and PCR-based analysis. Their services cater to healthcare providers and research institutions seeking precise genomic data for clinical decision-making. By integrating bioinformatics with clinical genetics, the company aims to improve patient outcomes through personalized medicine and early disease detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Genetic Engineering.